Fig 9 - by Farshid Maleki (20521649)

Subjects:

Apparent density of pristine and modified Egyptian kaolin sintered at two temperatures: 900 and 1050 °C. by Nasser A. M. Barakat (11705885)

Subjects:

Water absorption of pristine and modified Egyptian kaolin sintered at two temperatures: 900 and 1050 °C. by Nasser A. M. Barakat (11705885)

Subjects:

Trypan blue dye exclusion assay for cell viability evaluation (% of control). by Farshid Maleki (20521649)

Subjects:

Percentage change in the apparent density of pristine and modified Egyptian kaolin sintered at 1050 °C for 4 successive cycles. by Nasser A. M. Barakat (11705885)

Subjects:

Fig 7 - by Farshid Maleki (20521649)

Subjects:

Porosity of pristine and modified Egyptian kaolin sintered at two temperatures: 900 and 1050 °C. by Nasser A. M. Barakat (11705885)

Subjects:

Rate of apoptosis in MDA-MB-231 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C). by Farshid Maleki (20521649)

Subjects:

Fig 10 - by Farshid Maleki (20521649)

Subjects:

XRD pattern for the prepared silicon oxide nanoparticles. by Nasser A. M. Barakat (11705885)

Subjects:

Fig 5 - by Farshid Maleki (20521649)

Subjects:

Fig 6 - by Farshid Maleki (20521649)

Subjects:

Summary of nanostructured additives used in this study, including type, morphology, dimensions, and source or preparation method. by Nasser A. M. Barakat (11705885)

Subjects:

Rate of apoptosis in MCF-7 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C). by Farshid Maleki (20521649)

Subjects:

SEM images showing the microstructure of pristine kaolin. by Nasser A. M. Barakat (11705885)

Subjects:

Thermal gravimetric analyses and the first derivative for the obtained data for the CNTs; (A and B), AC; (C and D) and SiO₂; (E and F) compared with the pristine kaolin. by Nasser A. M. Barakat (11705885)

Subjects:

Effect of each additive on Kaolin ceramic properties at different sintering temperatures. by Nasser A. M. Barakat (11705885)

Subjects:

Chart illustrates the treated groups (BM-MSC1, BM-MSC2, AD-MSC1, AD-MSC2) increasing in cell viability over replicates, while the untreated groups (Un-BM1, Un-BM2, Un-AD1, Un-AD2)... by Alani Mohanad Khalid Ahmed (22693496)

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size. by Francesca Catto (21253435)

“…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …”

Supplementary Material for: Decreased Lactococcus lactis and propionic acid in feces of patients with Moyamoya disease: Possible implications of immune dysregulation by figshare admin karger (2628495)

“…The gut microbiota produces short-chain fatty (SCFA) and organic acids, influencing immune regulation and vascular remodeling. We aimed to characterize the gut microbiota in patients with MMD. …”